contact@welcomeurope.com

HORIZON EUROPE – HORIZON-JU-GH-EDCTP3-2025-01-two-stage – 2025

Horizon Europe - Horizon Europe aims to strengthen the EU's science and technology base and the European Research Area (ERA), to boost Europe's innovation capacity, competitiveness and employment, and to deliver on citizens' priorities, supporting our socio-economic model and values.

2025-03-20
Detailed budget by topic below
Close

Call synthesis

Call reference HORIZON-JU-GH-EDCTP3-2025-01-two-stage
Programme Horizon Europe Programme
Institution European Commission
Sectors Business & Industry Civil Protection & Risks Cooperation & Development Culture, Media & Communication Health Research & Innovation Territorial Development
Beneficiaries Association & NGO EU & International Organisation Large company (> 250 employees) Media & cultural organisation Research centre & university Smes & Start-Ups (< 249 Employees)

Content reserved for subscribers

Call reference

HORIZON-JU-GH-EDCTP3-2025-01-two-stage



Register for free to access the content

Free access to all information

Priorities and funded actions

Objectives 

  • To increase international cooperation among researchers and funders, catalyse research synergies, and leverage resources and investments in order to achieve the reduction of disease burden in SSA through the development of vaccines
  • To increase international cooperation among researchers and funders, catalyse research synergies, and leverage resources and investments in order to achieve rapid advances in the development of new or improved anti-malarial drugs or drug combinations
  • To progress the development of prophylactic vaccines against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa

TOPICS: 

Open 

  • HORIZON-JU-GH-EDCTP3-2025-01-TB-01-two-stage: Global collaboration action for the development of vaccines for reducing the disease burden of Tuberculosis in sub-Saharian Africa
  • HORIZON-JU-GH-EDCTP3-2025-01-MALARIA-02-two-stage: Global collaboration action for research on existing Malaria therapeutics and clinical development of new antimalarial candidates
  • HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage: Accelerating the development of prophylactic vaccines against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa

Additional information 

To find your national contact point: Click here

Useful 

Financement
  • Total budget of the call: Detailed budget below
  • Budget per topic:
    • HORIZON-JU-GH-EDCTP3-2025-01-TB-01-two-stage: 45.900.000 euros
    • HORIZON-JU-GH-EDCTP3-2025-01-MALARIA-02-two-stage: 30.900.000 euros
    • HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage: 45.900.000 euros